The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.

Abstract

Whole-body scintigraphy with 131I-meta-iodo-benzylguanidine 131I-MIBG) was performed in 41 patients with neuroblastoma. In patients with clinical remission no pathological concentration of 131I-MIBG was found. In 30 patients with residual, recurrent or metastatic disease neuroblastoma was correctly localized by 131I-MIBG scintigraphy. It is concluded that 131I-MIBG whole-body scintigraphy is useful in the diagnosis and follow-up of neuroblastoma.

Cite this paper

@article{Zagar1993TheCU, title={The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.}, author={Ivana Zagar and Sascha Mitrovic and G Adanja and L J Maksimovic and Petar Ilija Ivanovski and Ruining Han and Ksenija Kovaci{\'c}}, journal={Medicinski pregled}, year={1993}, volume={46 Suppl 1}, pages={74-5} }